About Christina Psaros, PhD

Dr. Christina Psaros is the Associate Director of the Behavioral Medicine Program at Massachusetts General Hospital (MGH), where she is also a staff psychologist. She is also an Associate Professor of Psychology in the Department of Psychiatry at Harvard Medical School (HMS). Dr. Psaros received her Ph.D. in clinical psychology (with a Health Psychology concentration) from Drexel University in 2008, and did her predoctoral internship and postdoctoral fellowship at MGH/HMS.

Dr. Psaros' clinical practice focuses on women's mental health, particularly the treatment of mood and anxiety disorders as they occur during infertility, pregnancy, and the postpartum. Dr. Psaros' research focus is on understanding psychosocial aspects of HIV care and prevention, and developing interventions to support health, particularly among women. She has active projects in both the U.S. and sub-Saharan Africa. Dr. Psaros has over 70 peer-reviewed publications, and has written two book chapters. She has served or is currently serving as the principal investigator for six NIH-funded grants in the area of HIV, and serves as an ad hoc reviewer for over 20 peer-reviewed journals. She also mentors and supervises trainees in the Behavioral Medicine Service.

Clinical Interests:

Treats:

Locations

Psychiatry
One Bowdoin Square
Boston,  02114-2927
Phone: 617-724-5600
Phone: 617-726-7458
Fax: 617-724-8690

Medical Education

  • PHD, Drexel University
  • Fellowship, Massachusetts General Hospital

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

I have developed expertise in both women’s health and HIV, and these interests have merged into a program of research that addresses psychosocial aspects of HIV care and prevention, particularly among women and underserved populations, in both domestic and international settings. Much of my work occurs in the province of KwaZulu-Natal, South Africa, an HIV hyperendemic setting that has the highest concentration of pregnant women living with HIV in the world. I am currently leading a large prospective cohort study (NIMH 112385) that aims to identify factors that influence postpartum attrition from HIV care among women in KZN—an important and understudied link in the HIV cascade that is critical to public health goals to end the epidemic.

Recent work has focused on developing interventions to support adherence to pre-exposure prophylaxis (PrEP) for prevention of HIV. I led the design of an adherence intervention for serodiscordant couples participating in the Partners PrEP trial in Uganda; ours is the first published adherence intervention for individuals using PrEP. I also led the design and execution of PrEP adherence interventions in collaboration with colleagues at the Fenway Institute/Fenway Health and currently serve as Co-PI (with Kenneth Mayer, MD) of an Adolescent Trials Network (ATN) funded-study (NICHD 089881) in which we are adapting a PrEP adherence intervention to meet the needs of young men who have sex with men. Lastly, I am a member of the protocol team for HIV Prevention Trials Network (HPTN) study 083. As part of this work, I developed an ancillary proposal to collect qualitative data from participants on this study to better inform our understanding of how to deliver and implement injectable PrEP.

Publications